Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Diabetes Mellitus, Insulin-Dependent, 12 × Nivolumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 4 OTHER 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 2 Thymoma 1 Small Cell Lung Carcinoma 1 Recurrent Squamous Cell Lung Carcinoma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Gastric and Esophagogastric Junction Adenocarcinoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Advanced Solid Tumors 1 Adenocarcinoma 1

Interventions

Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02046733 2024-11-08

STIMULI

ETOP IBCSG Partners Foundation

Phase 2 Completed

222 enrolled 18 charts

Diabetes Mellitus, Insulin-Dependent, 12, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡